Arabic Arabic English English French French German German
dark

Surface Oncology Appoints Denice Torres to Board of Directors

Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced that Denice Torres will join the company’s board of directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation.

Next Post

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Esophageal Squamous Cell Carcinoma (ESCC)

Related Posts
Total
0
Share